BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape

Invisible chemical impurities in medicines can pose very visible risks to patient safety and pharmaceutical reputations. In recent years, a quiet c...

August 19, 2025 | Analysis

South Korea’s GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Plasma-Derived Medicines Workforce in Thailand

GC Biopharma , a South Korean biopharmaceutical company, announced that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Soc...

August 19, 2025 | News

GenScript Biotech CEO Sherry Shao Champions Innovation and Global Expansion as H1 2025 Profits Surge Over 500%

GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 20...

August 18, 2025 | Company results

Axplora Invests €6.5 Million to Expand Vizag Facility as USFDA-Cleared Indian Sites Strengthen Global Strategy

Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production ca...

August 06, 2025 | News

WuXi XDC’s New DP3 Facility Achieves GMP Release, Boosting Global Bioconjugate Manufacturing Capacity

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...

August 05, 2025 | News

WuXi Biologics China PFS Site Clears FDA Inspection

WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...

July 22, 2025 | News

FDA Publishes First-Ever Public Database of Complete Response Letters (2020–2024) – Now Available for Download

Download Approved CRLs – 2020 to 2024 (external link) U.S. Food and Drug Administration (FDA) has, for the first time, made pub...

July 14, 2025 | Regulatory

Ascletis Doses First Participants in U.S. Phase IIa Trial of Oral Small Molecule GLP-1 Agonist ASC30 for Obesity

- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a ...

July 03, 2025 | News

EVA Pharma and Zhejiang Jinhua CONBA Forge Strategic Alliance to Reinforce Global Healthcare Supply Chains

Two Regional Powerhouses to Strengthen Cross-Border Collaboration for a More Resilient and Accessible Healthcare Supply Chain EVA Pharma, one of the leadi...

June 30, 2025 | News

Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...

June 27, 2025 | News

Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts

Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...

June 19, 2025 | News

Sartorius Expands Aubagne Campus in France to Boost Global Fluid Management Capabilities

Extended campus at headquarters of French sub-group Sartorius Stedim Biotech in Aubagne Significantly increased capacities for manufacturing, logistics,...

June 19, 2025 | News

Specialised Therapeutics Expands Incyte Partnership to Launch Axatilimab and Retifanlimab in Asia-Pacific

Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agree...

June 13, 2025 | News

Sweden’s Salipro Biotech Partners with South Korea’s Daewoong Pharmaceutical to Target Challenging Drug Discovery

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance...

June 12, 2025 | News

Stay Connected